LATEST NEWS

Jul 26, 2021
Cytox strengthens management team to support commercialisation of genoSCORE test to predict risk of cognitive decline due to Alzheimer’s disease
Jul 16, 2021
Cytox appoints BERBĒS as market developer in Spain, to introduce a new test that predicts the risk of cognitive decline due to Alzheimer’s disease
Jun 23, 2021
Infinity BiologiX and Cytox collaborate to provide new genetic test to predict the risk of cognitive decline due to Alzheimer’s disease

NEWSLETTERS

Cytox welcomes Aduhelm
Cytox launches genoSCORE-LAB
New Products and Approaches

Meet the Team